The Technical Analyst
RegeneRx [RGRX]
Exchange: PNK Industry: Biotechnology
RegeneRx Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0014
America/New_York / 1 mai 2024 @ 13:15
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.210 mill |
| EPS: | -0.0100 |
| P/E: | -0.140 |
| Earnings Date: | N/A |
| SharesOutstanding: | 149.70 mill |
| Avg Daily Volume: | 0.0001 mill |
| RATING 2024-04-17 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | ||
| Gr.Profit | n/a | n/a | n/a | n/a | ||
| Ebit | n/a | |||||
| Asset | n/a | |||||
| Debt | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.140 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.140 | industry: PE -107.25 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ -0.0806 - 0.0834 ( +/- 5 857.14%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-07-03 | Essetifin Spa | Buy | 3 750 000 | Common Stock Warrant (right to buy) |
| 2023-07-03 | Essetifin Spa | Buy | 0 | Convertible Promissory Note (right to buy) |
| 2022-05-17 | Goldstein Allan L | Buy | 480 000 | Stock Option (Right to Buy) |
| 2022-05-17 | Goldstein Allan L | Buy | 480 000 | Stock Option (Right to Buy) |
| 2022-05-17 | Bove Mauro | Buy | 240 000 | Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 100.00 |
| Last 98 transactions |
| Buy: 35 451 124 | Sell: 5 867 027 |
Forecast: